Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections (2021)
- Authors:
- Autor USP: ARRUDA NETO, EURICO DE - FMRP
- Unidade: FMRP
- DOI: 10.1101/2021.09.28.21264242
- Subjects: ANTIRRETROVIRAIS; COVID-19; ENSAIO CLÍNICO; AGENTE TÓXICO
- Keywords: Tenofovir; RNA-dependent RNA polymerase inhibitors; SARS-CoV-2; COVID-19; Cytokines; Chemokines; nucleoside / nucleotide analogues
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: MedRXiv
- Volume/Número/Paginação/Ano: Preprint, on-line, p. 1-27, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ARRUDA, E. A. G. et al. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, p. 1-27, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.09.28.21264242. Acesso em: 27 jan. 2026. -
APA
Arruda, E. A. G., Pires-Neto, R. J., Medeiros, M. S., Quirino-Filho, J., Clementino, M., Gondim, R. N. D. G., et al. (2021). Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, 1-27. doi:10.1101/2021.09.28.21264242 -
NLM
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1101/2021.09.28.21264242 -
Vancouver
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1101/2021.09.28.21264242 - Viral respiratory tract illnesses in a developing tropical area: prospective studies in goncalves dias, fortaleza, brazil
- Oropouche virus in vitro infection of human peripheral blood mononuclear cells
- Comparative susceptibilities of human embryonic fibroblasts and cells for isolation of human rhinoviruses
- Analysis of clinical strains of human respiratory syncytial virus and susceptibility to neutralization by palivizumab
- Patogênese viral: interações vírus-célula e vírus organismo
- Development of a duplex RT-PCR assay for the detection of influenza virus in clinical samples and comparison with quick-vue and viral isolation in shell vial
- Brazilian Congress of Virology, 24. Mercosur Meeting of Virology, 8
- Human bocavirus respiratory infections in children
- Human bocavirus in very young infants hospitalized with acute respiratory infection in northeast Brazil [Carta]
- Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection
Informações sobre o DOI: 10.1101/2021.09.28.21264242 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003230127.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
